{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:35:01Z","timestamp":1784309701042,"version":"3.55.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012599","name":"Bethlehem Griffiths Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1141046"],"award-info":[{"award-number":["APP1141046"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1708"],"award-info":[{"award-number":["1708"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jtha.2024.04.023","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T12:28:32Z","timestamp":1715689712000},"page":"2331-2344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Development of endothelial-targeted CD39 as a therapy for ischemic stroke"],"prefix":"10.1016","volume":"22","author":[{"given":"Natasha Ting","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Savvidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Selan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Calvello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Brkljaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbey","family":"Willcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne S.J.","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlheinz","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Medcalf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshal H.","family":"Nandurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9712-4784","authenticated-orcid":false,"given":"Maithili","family":"Sashindranath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.04.023_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","article-title":"Pathobiology of ischaemic stroke: an integrated view","volume":"22","author":"Dirnagl","year":"1999","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jtha.2024.04.023_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1749-6632.2012.06691.x","article-title":"Pathobiology of injury after stroke: the neurovascular unit and beyond","volume":"1268","author":"Dirnagl","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jtha.2024.04.023_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","article-title":"The science of stroke: mechanisms in search of treatments","volume":"67","author":"Moskowitz","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.jtha.2024.04.023_bib4","first-page":"e21","article-title":"Heart disease and stroke statistics\u20142009 update a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.04.023_bib5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.STR.0000116183.50167.D9","article-title":"Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study","volume":"35","author":"Hardie","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2024.04.023_bib6","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1097\/00000542-199412000-00028","article-title":"Metabolism of glucose, glycogen, and high-energy phosphates during complete cerebral ischemia. A comparison of normoglycemic, chronically hyperglycemic diabetic, and acutely hyperglycemic nondiabetic rats","volume":"81","author":"Wagner","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtha.2024.04.023_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13054-017-1670-9","article-title":"Clinical pathophysiology of hypoxic ischemic brain injury after cardiac arrest: a \"two-hit\" model","volume":"21","author":"Sekhon","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2024.04.023_bib8","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1161\/CIRCULATIONAHA.106.670885","article-title":"Acute ischemic stroke treatment in 2007","volume":"116","author":"Goldstein","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.04.023_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1254\/jphs.10R27FM","volume":"116","author":"Suzuki","year":"2011","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jtha.2024.04.023_bib10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.expneurol.2005.01.004","article-title":"Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex","volume":"193","author":"Carmichael","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jtha.2024.04.023_bib11","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1038\/jcbfm.2012.139","article-title":"Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis?","volume":"32","author":"Dalkara","year":"2012","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.jtha.2024.04.023_bib12","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1161\/STROKEAHA.111.000544","article-title":"Ultra-sensitive molecular MRI of vascular cell adhesion molecule-1 reveals a dynamic inflammatory penumbra after strokes","volume":"44","author":"Gauberti","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2024.04.023_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/10623329509024651","article-title":"Differential regulation of adhesion molecule expression by human cerebrovascular and umbilical vein endothelial cells","volume":"2","author":"McCarron","year":"1995","journal-title":"Endothelium"},{"key":"10.1016\/j.jtha.2024.04.023_bib14","first-page":"24","article-title":"Induction of B7.1 and B7.2 co-stimulatory molecule on the surface of human brain endothelial cells [abstract]","volume":"90","author":"Prat","year":"1998","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jtha.2024.04.023_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-5728(92)90170-P","article-title":"Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide","volume":"39","author":"Wong","year":"1992","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jtha.2024.04.023_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/mvre.1995.1028","article-title":"Expression of vascular cell adhesion molecule-1 (VCAM-1) by human brain microvessel endothelial cells in primary culture","volume":"49","author":"Wong","year":"1995","journal-title":"Microvasc Res"},{"key":"10.1016\/j.jtha.2024.04.023_bib17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12974-022-02601-z","article-title":"Blocking P2X7 by intracerebroventricular injection of P2X7-specific nanobodies reduces stroke lesions","volume":"19","author":"Wilmes","year":"2022","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.jtha.2024.04.023_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/pr.110.003129","article-title":"Activation and regulation of purinergic P2X receptor channels","volume":"63","author":"Coddou","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jtha.2024.04.023_bib19","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1083\/jcb.139.7.1635","article-title":"Extracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively targeting NF-kappaB p65","volume":"139","author":"Ferrari","year":"1997","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jtha.2024.04.023_bib20","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.STR.25.7.1481","article-title":"Tumor necrosis factor-alpha expression in ischemic neurons","volume":"25","author":"Liu","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2024.04.023_bib21","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.jcbfm.9600217","article-title":"Experimental stroke induces massive, rapid activation of the peripheral immune system","volume":"26","author":"Offner","year":"2006","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.jtha.2024.04.023_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41419-019-1716-9","article-title":"Microglia-derived TNF-\u03b1 mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jtha.2024.04.023_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1084\/jem.185.1.153","article-title":"Loss of ATP diphosphohydrolase activity with endothelial cell activation","volume":"185","author":"Robson","year":"1997","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jtha.2024.04.023_bib24","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1172\/JCI0210649","article-title":"Elucidation of the thromboregulatory role of CD39\/ectoapyrase in the ischemic brain","volume":"109","author":"Pinsky","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2024.04.023_bib25","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1111\/j.1600-6143.2010.03257.x","article-title":"Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury","volume":"10","author":"Crikis","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jtha.2024.04.023_bib26","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1172\/JCI19560","article-title":"Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation","volume":"113","author":"Dwyer","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2024.04.023_bib27","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1161\/ATVBAHA.111.226373","article-title":"Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target","volume":"31","author":"Straub","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.04.023_bib28","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1182\/blood-2012-08-449694","article-title":"Delayed targeting of CD39 to activated platelet GPIIb\/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?","volume":"121","author":"Hohmann","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.023_bib29","article-title":"ADPase CD39 fused to glycoprotein VI-Fc boosts local antithrombotic effects at vascular lesions","volume":"6","author":"Degen","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2024.04.023_bib30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1179\/1743132813Y.0000000211","article-title":"Magnetic resonance imaging of perfusion-diffusion mismatch in rodent and non-human primate stroke models","volume":"35","author":"Duong","year":"2013","journal-title":"Neurol Res"},{"key":"10.1016\/j.jtha.2024.04.023_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.brainres.2010.11.087","article-title":"Chemokine-related gene expression in the brain following ischemic stroke: no role for CXCR2 in outcome","volume":"1372","author":"Brait","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.jtha.2024.04.023_bib32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41598-018-36598-4","article-title":"Spatio-temporal overview of neuroinflammation in an experimental mouse stroke model","volume":"9","author":"Buscemi","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2024.04.023_bib33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1085\/jgp.201210875","article-title":"Purinergic regulation of inflammasome activation after central nervous system injury","volume":"140","author":"Bernier","year":"2012","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.jtha.2024.04.023_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-017-0904-8","article-title":"The role of microglial P2X7: modulation of cell death and cytokine release","volume":"14","author":"He","year":"2017","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.jtha.2024.04.023_bib35","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41386-018-0141-6","article-title":"Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia","volume":"43","author":"Bhattacharya","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jtha.2024.04.023_bib36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular mechanisms regulating NLRP3 inflammasome activation","volume":"13","author":"Jo","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jtha.2024.04.023_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood.V94.1.179.413k18_179_185","article-title":"von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation","volume":"94","author":"van Mourik","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.023_bib38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/bcpt.12413","article-title":"Ascorbic acid reduces the adverse effects of delayed administration of tissue plasminogen activator in a rat stroke model","volume":"117","author":"Allahtavakoli","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jtha.2024.04.023_bib39","first-page":"257","article-title":"Thrombolytic therapy in experimental embolic stroke","volume":"6","author":"Overgaard","year":"1994","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"10.1016\/j.jtha.2024.04.023_bib40","article-title":"Embolic middle cerebral artery occlusion (MCAO) for ischemic stroke with homologous blood clots in rats","author":"Jin","year":"2014","journal-title":"J\u00a0Vis Exp"},{"key":"10.1016\/j.jtha.2024.04.023_bib41","article-title":"Tissue plasminogen activator neurotoxicity is neutralized by recombinant ADAMTS 13","volume":"6","author":"Fan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2024.04.023_bib42","article-title":"Characterization of a novel model of global forebrain ischaemia\u2013reperfusion injury in mice and comparison with focal ischaemic and haemorrhagic stroke","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2024.04.023_bib43","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.clinbiochem.2006.09.014","article-title":"Levels of vascular cell adhesion molecule-1 and endothelin-1 in ischemic stroke: a longitudinal prospective study","volume":"40","author":"Brondani","year":"2007","journal-title":"Clinical Biochem"},{"key":"10.1016\/j.jtha.2024.04.023_bib44","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1161\/01.STR.25.9.1794","article-title":"Role of angiogenesis in patients with cerebral ischemic stroke","volume":"25","author":"Krupinski","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2024.04.023_bib45","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00001721-199907000-00009","article-title":"Soluble intercelluar adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke","volume":"10","author":"Blann","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2024.04.023_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.STR.32.1.63","article-title":"Delay in presentation and evaluation for acute stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (STROKE)","volume":"32","author":"Lacy","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2024.04.023_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1164\/rccm.200809-1433OC","article-title":"Anchoring fusion thrombomodulin to the endothelial lumen protects against injury-induced lung thrombosis and inflammation","volume":"180","author":"Ding","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtha.2024.04.023_bib48","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1182\/blood-2007-07-103002","article-title":"Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature","volume":"111","author":"Ding","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.023_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080110","article-title":"Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor","volume":"8","author":"Greineder","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2024.04.023_bib50","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/bloodadvances.2017007229","article-title":"ICAM-1-targeted thrombomodulin mitigates tissue factor-driven inflammatory thrombosis in a human endothelialized microfluidic model","volume":"1","author":"Greineder","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.04.023_bib51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2019.03.008","article-title":"Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain","volume":"301","author":"Marcos-Contreras","year":"2019","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.jtha.2024.04.023_bib52","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.1912012117","article-title":"Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier","volume":"117","author":"Marcos-Contreras","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.04.023_bib53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2023.02.037","article-title":"Targeted drug delivery to the brain endothelium dominates over passive delivery via vascular leak in experimental intracerebral hemorrhage","volume":"356","author":"Reyes-Esteves","year":"2023","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.jtha.2024.04.023_bib54","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.jcbfm.9600198","article-title":"Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice","volume":"26","author":"Justicia","year":"2006","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.jtha.2024.04.023_bib55","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1161\/CIRCULATIONAHA.116.023301","article-title":"Ischemic cerebroprotection conferred by myeloid lineage-restricted or global CD39 transgene expression","volume":"135","author":"Baek","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.04.023_bib56","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jhep.2017.05.021","article-title":"CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury","volume":"67","author":"Savio","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jtha.2024.04.023_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.3792-03.2004","article-title":"Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia","volume":"24","author":"Suzuki","year":"2004","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jtha.2024.04.023_bib58","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1172\/JCI65167","article-title":"MFGE8 inhibits inflammasome-induced IL-1\u03b2 production and limits postischemic cerebral injury","volume":"123","author":"Deroide","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2024.04.023_bib59","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/jcbfm.2013.242","article-title":"NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke","volume":"34","author":"Yang","year":"2014","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.jtha.2024.04.023_bib60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00281-023-00987-3","article-title":"The role of the ATP-adenosine axis in ischemic stroke","volume":"45","author":"Sch\u00e4dlich","year":"2023","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jtha.2024.04.023_bib61","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtha.2024.04.023_bib62","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1182\/blood-2007-10-117044","article-title":"A2B adenosine receptor dampens hypoxia-induced vascular leak","volume":"111","author":"Eckle","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.04.023_bib63","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1172\/JCI27933","article-title":"The A2B adenosine receptor protects against inflammation and excessive vascular adhesion","volume":"116","author":"Yang","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2024.04.023_bib64","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","article-title":"Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke","volume":"282","author":"Clark","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.04.023_bib65","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nm0298-228","article-title":"Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice","volume":"4","author":"Wang","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2024.04.023_bib66","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.neuropharm.2009.12.017","article-title":"Blood-brain barrier permeability and tPA-mediated neurotoxicity","volume":"58","author":"Abu","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jtha.2024.04.023_bib67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/83358","article-title":"The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling","volume":"7","author":"Nicole","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2024.04.023_bib68","article-title":"Blood-brain barrier disruption and hemorrhagic transformation in acute ischemic stroke: systematic review and meta-analysis","volume":"11","author":"Arba","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.jtha.2024.04.023_bib69","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12987-017-0081-2","article-title":"LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH","volume":"14","author":"Niego","year":"2017","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jtha.2024.04.023_bib70","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5847\/wjem.j.1920-8642.2017.01.006","article-title":"Comparison of neurological clinical manifestation in patients with hemorrhagic and ischemic stroke","volume":"8","author":"Ojaghihaghighi","year":"2017","journal-title":"World J Emerg Med"},{"key":"10.1016\/j.jtha.2024.04.023_bib71","series-title":"No postcode untouched: stroke in Australia 2020","author":"Economics","year":"2020"},{"key":"10.1016\/j.jtha.2024.04.023_bib72","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/STROKEAHA.107.501643","article-title":"Stroke in rural areas and small communities","volume":"39","author":"Joubert","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2024.04.023_bib73","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.STR.21.5.801","article-title":"Collagenase-induced intracerebral hemorrhage in rats","volume":"21","author":"Rosenberg","year":"1990","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2024.04.023_bib74","doi-asserted-by":"crossref","DOI":"10.1007\/s12975-017-0554-2","article-title":"Precision stroke animal models: the permanent MCAO model should be the primary model, not transient MCAO","author":"McBride","year":"2017","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.jtha.2024.04.023_bib75","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/sj.jcbfm.9600548","article-title":"Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion","volume":"28","author":"MacLellan","year":"2008","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.jtha.2024.04.023_bib76","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","article-title":"Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2024.04.023_bib77","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40035-022-00291-4","article-title":"Impaired glymphatic function in the early stages of disease in a TDP-43 mouse model of amyotrophic lateral sclerosis","volume":"11","author":"Zamani","year":"2022","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.jtha.2024.04.023_bib78","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1093\/brain\/aws178","article-title":"The tissue-type plasminogen activator\u2013plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans","volume":"135","author":"Sashindranath","year":"2012","journal-title":"Brain"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624002812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624002812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:09:03Z","timestamp":1778818143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624002812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1538783624002812"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.04.023","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.12.571382","asserted-by":"object"}]},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of endothelial-targeted CD39 as a therapy for ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}